Company

Presentations

For over 30 years, SYMATESE has provided its experience and its know-how in the field of biopolymers extraction and transformation for the development of medical devices to companies of the medical and pharmaceutical sector.

Since its creation SYMATESE has invested in R & D to develop innovative medical device for itself as well as its Partner, based on its scientific and clinical Know-How.
Thus SYMATESE has become a recognized bovine collagen manufacturer and hyaluronic acid manufacturer.
Medical devices marketed by SYMATESE are designed and manufactured according to international regulatory requirements for commercialisation on world markets.
SYMATESE is known for the quality of its products, its capacity for innovation as well as the competence and expertise of its employees. The renewed confidence of the leading partners in various fields of activity associated to the performances of our products, places SYMATESE in a leading position.

SYMATESE is certified according to the most stringent international regulatory requirements (ISO 13485 and QSR – 21 CFR part 820). which guarantees the permanent control of the quality and the efficiency of its products. Good Manufacturing Practices (GMP, Quality System Regulation CFR820) and European directive MDD93/42 constitute the regulatory basis of the SYMATESE quality management system. All our products are CE marked.

Management

Jean-Paul Gérardin

CEO

SYMATESE has expertise and know-how in the field of extraction and transformation of biopolymers for the development of innovative medical devices in order to improve the quality of life of patients around the world . Being a recognized bovine collagen manufacturer and hyaluronic acid manufacturer.

SYMATESE through its Business to Business activity, designs and manufactures innovative products for medical, pharmaceuticals and cosmetics applications.

SYMATESE is present in medical fields such as Vascular and Visceral surgery, orthopedic surgery, burns and dermal reconstruction, ophthalmology, plastic surgery, general surgery and aesthetics surgery.

SYMATESE is recognized for the quality and knowledge of its employee who share the same values: Ethics, Innovation, Vision and Flexibility. We focus on a scientific, medical and financial outcomes in order to bring value to the patients and our customers.

History

1982

1986

1997

2001

2003

2008

2010

2012

2013

1982

Creation of the SADUC company established as a bovine collagen manufacturer for cosmetic and pharmaceutical applications in CHAPONOST (Near Lyon – FRANCE).

1986

Institut Mérieux acquires SADUC to develop medical applications.

1997

Laboratoire Perouse Implant (L.P.I.), specialised in cardiovascular prostheses, takes over the activities of SADUC at the Chaponost site.

2001

SYMATESE biomatériaux is created after the split of the PEROUSE companies and takes over all the biomaterial activities of LPI. Since this date, the aspects relating to the product design are developed with the creation of a specific department dedicated and the domains of the research have been extended to other biopolymers than collagen such as hyaluraonic acid, oxidized cellulose, alginate.

2003

CE approval of the first 2 own collagen based products. These are HEMOTESE® haemostatic compress and COLLAPAT® II haemostatic bone substitute.

2008

Separation from the Perouse medical group Creation of holding called HOLDSYMA with the same shareholding as PEROUSE MEDICAL. PEROUSE MEDICAL (part of VYGON) remains a partner of SYMATESE.

2010

SYMATESE biomatériaux becomes SYMATESE.

2012

Creation of the subsidiary SYMATESE Aesthetics, dedicated to the design and the manufacturing of high Quality innovative Products for plastic surgery.

2013

Acquisition of a new plant in Chaponost (Lyon – FRANCE) of 3000 m2 dedicated to activity extension, which doubles the previous SYMATESE’s surface CE approval of the third own collagen based products, NEVELIA® which is a bi-layer matrix for dermal regeneration used in the reconstructive surgery and in the burns treatment.

Missions & values

Ambition

Join the restricted group of world leaders in the field of extraction and transformation of biopolymers intended for implantable medical devices, cosmetic products and in-vitro applications. And be recognized for:

Our capacity for innovation

The quality of our services

The skill of our collaborators

Vision

Improve health and the quality of life of the patients

Mission

Provide patients, healthcare professionals and companies of the medical, pharmaceutical and cosmetic sector, with innovative products stemming from our technological platforms and intended for the world markets.

OUR KNOWLEDGE / OUR KNOW-HOW

The extraction, the transformation, the chemistry and the shaping of biopolymers such as collagens including bovine collagen type I, cross linked hyaluronic acid, cellulose, alginate etc…
The design and the manufacturing of medical devices according to international quality and regulatory requirements thanks to a continuous improvement approach to optimize the « time to market ».